Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)
Elanco Animal Health's (ELAN) quarterly Asset Writedowns and Impairment came in at $47.0 million in Q4 2025, up 840.0% year-on-year from $5.0 million in Q4 2024, and up 95.83% quarter-over-quarter from $24.0 million in Q3 2025.
Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends
Elanco Animal Health has disclosed Asset Writedowns and Impairment across 9 years of filings, most recently posting $47.0 million for Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $47.0 million, up 840.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.0 million (up 75.0% YoY), and the FY2025 annual result was $71.0 million, down 12.35% from the prior year.
- Asset Writedowns and Impairment came in at $47.0 million for Q4 2025 at Elanco Animal Health, up from $24.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $275.0 million in Q2 2021 to a low of $5.0 million in Q4 2021.
- The 5-year median for Asset Writedowns and Impairment is $23.0 million (2022), against an average of $45.8 million.
- Across the five-year window, Asset Writedowns and Impairment surged 9066.67% in 2021 and slumped 81.48% in 2024, its largest moves.
- Elanco Animal Health's Asset Writedowns and Impairment stood at $5.0 million in 2021, then soared by 1080.0% to $59.0 million in 2022, then slumped by 54.24% to $27.0 million in 2023, then tumbled by 81.48% to $5.0 million in 2024, then jumped by 840.0% to $47.0 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $47.0 million (Q4 2025), $24.0 million (Q3 2025), and $5.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.00 Mn |
| Dec 31, 2025 | 47.00 Mn |
| Sep 30, 2025 | 24.00 Mn |
| Sep 30, 2025 | 24.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Dec 31, 2023 | 27.00 Mn |
| Dec 31, 2023 | 27.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2022 | 59.00 Mn |
| Jun 30, 2022 | 59.00 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Mar 31, 2022 | 22.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 56.00 Mn |
| Sep 30, 2021 | 56.00 Mn |